Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth Cornetta

Showing results (11-20 of 88) with videos related to

Pageof 9
Sort By:
Human Gene Therapy|January 8, 2020
The National Gene Vector Biorepository: Eleven Years of Providing Resources to the Gene Therapy CommunityKenneth Cornetta, Lorraine Matheson, Ryan Long, et al.
The Journal of General Virology|September 18, 2008
Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptorsQingwen Jin, Jon Marsh, Kenneth Cornetta, et al.
CSH Protocols|March 2, 2011
Transduction of cell lines by retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Retroviral vectors for gene transferKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Retroviral vector production by transient transfectionKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Generation of stable vector-producing cells for retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
Virology|November 17, 2009
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1Qingwen Jin, Bashar Alkhatib, Kenneth Cornetta, et al.
Pharmaceutical Research|March 21, 2007
Encapsulation of nucleic acids and opportunities for cancer treatmentLisa Brannon-Peppas, Bilal Ghosn, Krishnendu Roy, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical TrialsKenneth Cornetta, Sue Koop, Emily Nance, et al.
Molecular Therapy. Methods & Clinical Development|January 2, 2023
Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testingKenneth Cornetta, Tsai-Yu Lin, Danilo Pellin, et al.
Pageof 9

Showing results (11-20 of 88) with videos related to

Sort By:
Pageof 9
Human Gene Therapy|January 8, 2020
The National Gene Vector Biorepository: Eleven Years of Providing Resources to the Gene Therapy CommunityKenneth Cornetta, Lorraine Matheson, Ryan Long, et al.
The Journal of General Virology|September 18, 2008
Resistance to human immunodeficiency virus type 1 (HIV-1) generated by lentivirus vector-mediated delivery of the CCR5{Delta}32 gene despite detectable expression of the HIV-1 co-receptorsQingwen Jin, Jon Marsh, Kenneth Cornetta, et al.
CSH Protocols|March 2, 2011
Transduction of cell lines by retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Retroviral vectors for gene transferKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Retroviral vector production by transient transfectionKenneth Cornetta, Karen E Pollok, A Dusty Miller
CSH Protocols|March 2, 2011
Generation of stable vector-producing cells for retroviral vectorsKenneth Cornetta, Karen E Pollok, A Dusty Miller
Virology|November 17, 2009
Alternate receptor usage of neuropilin-1 and glucose transporter protein 1 by the human T cell leukemia virus type 1Qingwen Jin, Bashar Alkhatib, Kenneth Cornetta, et al.
Pharmaceutical Research|March 21, 2007
Encapsulation of nucleic acids and opportunities for cancer treatmentLisa Brannon-Peppas, Bilal Ghosn, Krishnendu Roy, et al.
Methods in Molecular Biology (Clifton, N.J.)|November 11, 2019
Replication-Competent Lentivirus Analysis of Vector-Transduced T Cell Products Used in Cancer Immunotherapy Clinical TrialsKenneth Cornetta, Sue Koop, Emily Nance, et al.
Molecular Therapy. Methods & Clinical Development|January 2, 2023
Meeting FDA Guidance recommendations for replication-competent virus and insertional oncogenesis testingKenneth Cornetta, Tsai-Yu Lin, Danilo Pellin, et al.
Pageof 9